US EPA: OSWER: Risk Assessment Guidance for Superfund, January[removed]Appendix C

First Page		Document Content
Date: 2012-12-18 12:29:54 Science Risk Pharmacokinetics Pharmacy Physiologically based pharmacokinetic modelling Toxicokinetics Risk assessment Quantitative structure–activity relationship Scientific Time Sharing Corporation Pharmaceutical sciences Toxicology Pharmacology		US EPA: OSWER: Risk Assessment Guidance for Superfund, January[removed]Appendix C Add to Reading List Source URL: www.epa.gov Download Document from Source Website File Size: 110,65 KB Share Document on Facebook

	JPPT Review Article Developmental Pharmacokinetics in Pediatric Populations Hong Lu, PhD and Sara Rosenbaum, PhD Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island DocID: 1vmzU - View Document
	Extrapolation of Fenfluramine Pharmacokinetics from Adults to Children: Estimating PK Exposure in Patients with Dravet Syndrome Li Zhang, Brooks Boyd, Christopher M. Rubino 1 METHODS DocID: 1v6zS - View Document
	Human Metabolism of a Novel Chemotherapeutic: Illuminating the Mechanisms of P450-Catalyzed Deboronation J. Scott Daniels Pharmacokinetics, Dynamics and Metabolism DocID: 1uU9P - View Document
	Plasma Protein Binding: Friend or Foe in Drug Discovery? Kevin Beaumont and Tristan Maurer Pharmacokinetics, Dynamics and Metabolism Pfizer Worldwide Research and Development Memorial Drive, Cambridge DocID: 1uQg4 - View Document
	Pharmacokinetics and efficacy of intraocular flurbiprofen DocID: 1uLR6 - View Document